Alumina Matrix Composite Ceramic Bearing Total Hip Arthroplasty in Patients Younger Than 30 Years

Seoul National University

Status: Unknown

Conditions: Advanced Hip Disease

Treatments: Device: THA using 4th generation CoC

Study type: Interventional

Funder types: Other

Identifiers

NCT01838096

Cera-001

Details and patient eligibility

About

This study will evaluate clinical outcome on patients who undergo cementless 4th generation ceramic (BIOLOX®delta, CeramTec GmbH, Plochingen, Germany) on ceramic (CoC) bearing total hip aArthroplasty ("THA") in patients younger than 30 years.

Enrollment: 92 patients

Sex: All

Ages: 15 to 30 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• younger than 30 years
• advanced hip disease

Exclusion criteria

• older than 30 years

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

92 participants in 1 patient group

THA

Experimental group

Treatment:

Device: THA using 4th generation CoC